(Business Insider) During his hedge fund’s quarterly conference call, Pershing Square CEO Bill Ackman dropped a big hint about what’s next for his largest position, Valeant Pharmaceuticals.”Fairly … soon Valeant will have identified a new specialty pharmacy to handle” the business that once belonged to Philidor Pharmacy, Ackman said.
We may find out more about that as early as Tuesday morning, when Valeant holds its own conference call, he hinted.
